{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:13:55Z","timestamp":1790910835689,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/ncpuro0711","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T12:39:43Z","timestamp":1170938383000},"page":"104-110","source":"Crossref","is-referenced-by-count":46,"title":["Mechanisms of Disease: hereditary leiomyomatosis and renal cell cancer\u2014a distinct form of hereditary kidney cancer"],"prefix":"10.1038","volume":"4","author":[{"given":"Sunil","family":"Sudarshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len","family":"Neckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Marston","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpuro0711_CR1","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1073\/pnas.051633798","volume":"98","author":"V Launonen","year":"2001","unstructured":"Launonen V et al. (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98: 3387\u20133392","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpuro0711_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP et al. (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30: 406\u2013410","journal-title":"Nat Genet"},{"key":"BFncpuro0711_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/jmg.2005.033506","volume":"43","author":"MH Wei","year":"2006","unstructured":"Wei MH et al. (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43: 18\u201327","journal-title":"J Med Genet"},{"key":"BFncpuro0711_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/376435","volume":"73","author":"JR Toro","year":"2003","unstructured":"Toro JR et al. (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73: 95\u2013106","journal-title":"Am J Hum Genet"},{"key":"BFncpuro0711_CR5","first-page":"4554","volume":"62","author":"M Kiuru","year":"2002","unstructured":"Kiuru M et al. (2002) Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 62: 4554\u20134557","journal-title":"Cancer Res"},{"key":"BFncpuro0711_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555553409416","volume":"53","author":"WB Reed","year":"1973","unstructured":"Reed WB et al. (1973) Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 53: 409\u2013416","journal-title":"Acta Derm Venereol"},{"key":"BFncpuro0711_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","volume":"12","author":"NA Alam","year":"2003","unstructured":"Alam NA et al. (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12: 1241\u20131252","journal-title":"Hum Mol Genet"},{"key":"BFncpuro0711_CR8","first-page":"739","volume":"16","author":"MJ Merino","year":"2003","unstructured":"Merino MJ et al. (2003) Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC); clinical, histopathological and molecular features of the first American families described [abstract]. Mod Pathol 16: 739","journal-title":"Mod Pathol"},{"key":"BFncpuro0711_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820\u2013823","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpuro0711_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1212\/WNL.40.3_Part_1.495","volume":"40","author":"C Gellera","year":"1990","unstructured":"Gellera C et al. (1990) Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes. Neurology 40: 495\u2013499","journal-title":"Neurology"},{"key":"BFncpuro0711_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/hmg\/10.7.763","volume":"10","author":"CA Friedrich","year":"2001","unstructured":"Friedrich CA (2001) Genotype\u2013phenotype correlation in von Hippel\u2013Lindau syndrome. Hum Mol Genet 10: 763\u2013767","journal-title":"Hum Mol Genet"},{"key":"BFncpuro0711_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng0594-85","volume":"7","author":"JR Gnarra","year":"1994","unstructured":"Gnarra JR et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85\u201390","journal-title":"Nat Genet"},{"key":"BFncpuro0711_CR13","first-page":"2852","volume":"54","author":"T Shuin","year":"1994","unstructured":"Shuin T et al. (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel\u2013Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54: 2852\u20132855","journal-title":"Cancer Res"},{"key":"BFncpuro0711_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jcp.2003.011767","volume":"57","author":"MR Morris","year":"2004","unstructured":"Morris MR et al. (2004) Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma. J Clin Pathol 57: 706\u2013711","journal-title":"J Clin Pathol"},{"key":"BFncpuro0711_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti D et al. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69: 49\u201354","journal-title":"Am J Hum Genet"},{"key":"BFncpuro0711_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/81551","volume":"26","author":"S Niemann","year":"2000","unstructured":"Niemann S and Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26: 268\u2013270","journal-title":"Nat Genet"},{"key":"BFncpuro0711_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal BE et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848\u2013851","journal-title":"Science"},{"key":"BFncpuro0711_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1086\/381054","volume":"74","author":"S Vanharanta","year":"2004","unstructured":"Vanharanta S et al. (2004) Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 74: 153\u2013159","journal-title":"Am J Hum Genet"},{"key":"BFncpuro0711_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1737","volume":"5","author":"E Gottlieb","year":"2005","unstructured":"Gottlieb E and Tomlinson IP (2005) Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5: 857\u2013866","journal-title":"Nat Rev Cancer"},{"key":"BFncpuro0711_CR20","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","volume":"94","author":"A Pause","year":"1997","unstructured":"Pause A et al. (1997) The von Hippel\u2013Lindau tumor-suppressor gene product forms a stable complex with human Cul-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 94: 2156\u20132161","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpuro0711_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin Jr","year":"2002","unstructured":"Kaelin WG Jr (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2: 673\u2013682","journal-title":"Nat Rev Cancer"},{"key":"BFncpuro0711_CR22","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1097\/01.ASN.0000092803.69761.41","volume":"14","author":"WG Kaelin Jr","year":"2003","unstructured":"Kaelin WG Jr (2003) The von Hippel\u2013Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol 14: 2703\u20132711","journal-title":"J Am Soc Nephrol"},{"key":"BFncpuro0711_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh CW and Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677\u2013684","journal-title":"Nat Med"},{"key":"BFncpuro0711_CR24","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","volume":"170","author":"WM Linehan","year":"2003","unstructured":"Linehan WM et al. (2003) The genetic basis of cancer of the kidney. J Urol 170: 2163\u20132172","journal-title":"J Urol"},{"key":"BFncpuro0711_CR25","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick RK and McKnight SL (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337\u20131340","journal-title":"Science"},{"key":"BFncpuro0711_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"AC Epstein","year":"2001","unstructured":"Epstein AC et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43\u201354","journal-title":"Cell"},{"key":"BFncpuro0711_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M et al. (2001) HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464\u2013468","journal-title":"Science"},{"key":"BFncpuro0711_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P et al. (2001) Targeting of HIF-\u03b1 to the von Hippel\u2013Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468\u2013472","journal-title":"Science"},{"key":"BFncpuro0711_CR29","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1073\/pnas.181341498","volume":"98","author":"F Yu","year":"2001","unstructured":"Yu F et al. (2001) HIF-1\u03b1 binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 98: 9630\u20139635","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpuro0711_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs JS et al. (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8: 143\u2013153","journal-title":"Cancer Cell"},{"key":"BFncpuro0711_CR31","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","volume":"93","author":"O Iliopoulos","year":"1996","unstructured":"Iliopoulos O et al. (1996) Negative regulation of hypoxia-inducible genes by the von Hippel\u2013Lindau protein. Proc Natl Acad Sci USA 93: 10595\u201310599","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpuro0711_CR32","first-page":"5215","volume":"61","author":"MS Wiesener","year":"2001","unstructured":"Wiesener MS et al. (2001) Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1\u03b1 in clear cell renal carcinomas. Cancer Res 61: 5215\u20135222","journal-title":"Cancer Res"},{"key":"BFncpuro0711_CR33","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard PJ et al. (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1\u03b1 in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14: 2231\u20132239","journal-title":"Hum Mol Genet"},{"key":"BFncpuro0711_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/path.1686","volume":"205","author":"P Pollard","year":"2005","unstructured":"Pollard P et al. (2005) Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome. J Pathol 205: 41\u201349","journal-title":"J Pathol"},{"key":"BFncpuro0711_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA et al. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-\u03b1 prolyl hydroxylase. Cancer Cell 7: 77\u201385","journal-title":"Cancer Cell"},{"key":"BFncpuro0711_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1469-1809.1979.tb00664.x","volume":"42","author":"YH Edwards","year":"1979","unstructured":"Edwards YH and Hopkinson DA (1979) The genetic determination of fumarase isozymes in human tissues. Ann Hum Genet 42: 303\u2013313","journal-title":"Ann Hum Genet"},{"key":"BFncpuro0711_CR37","doi-asserted-by":"publisher","first-page":"6282S","DOI":"10.1158\/1078-0432.CCR-050013","volume":"10 (Pt 2)","author":"WM Linehan","year":"2004","unstructured":"Linehan WM et al. (2004) Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res 10 (Pt 2): 6282S\u20136289S","journal-title":"Clin Cancer Res"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0711","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T21:34:45Z","timestamp":1707600885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BFncpuro0711"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0711","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}